• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绝经后期泌尿生殖系统症状的患病率

Prevalence of genito-urinary symptoms in the late menopause.

作者信息

Iosif C S, Bekassy Z

出版信息

Acta Obstet Gynecol Scand. 1984;63(3):257-60. doi: 10.3109/00016348409155509.

DOI:10.3109/00016348409155509
PMID:6730943
Abstract

One thousand two hundred women, aged 61, randomly selected from a defined geographical area in South Sweden, were interviewed by an anonymous questionnaire about their urogenital symptoms. Seventy-five percent co-operated, of whom 29.2% admitted to some degree of urinary incontinence and 48.8% some degree of lower genital tract disorder. Stress incontinence symptoms were reported by 11.8% of the women, urge incontinence by 7.9% and both types combined--"mixed" by 9.5%. Four percent of all women (18% of stress incontinence) experienced a loss sufficient to necessitate the wearing of a sanitary napkin or change of under clothing several times a day. Thirteen percent had repeated urinary tract infections. Itch, discharge and smarting pain was reported by 15%. Thirty-eight percent had vaginal dryness and dyspareunia. Only 4% of the women were undergoing estrogen therapy.

摘要

从瑞典南部一个特定地理区域随机抽取了1200名61岁的女性,通过一份匿名问卷对她们的泌尿生殖系统症状进行了调查。75%的人配合了调查,其中29.2%承认有某种程度的尿失禁,48.8%有某种程度的下生殖道疾病。11.8%的女性报告有压力性尿失禁症状,7.9%有急迫性尿失禁症状,两种类型都有的——“混合性”尿失禁为9.5%。所有女性中有4%(压力性尿失禁患者中的18%)出现了严重到每天需要使用卫生巾或多次更换内衣的情况。13%的人反复发生尿路感染。15%的人报告有瘙痒、分泌物和刺痛感。38%的人有阴道干燥和性交困难。只有4%的女性正在接受雌激素治疗。

相似文献

1
Prevalence of genito-urinary symptoms in the late menopause.绝经后期泌尿生殖系统症状的患病率
Acta Obstet Gynecol Scand. 1984;63(3):257-60. doi: 10.3109/00016348409155509.
2
Prevalence of genitourinary and other climacteric symptoms in 61-year-old women.
Maturitas. 1996 May;24(1-2):31-6. doi: 10.1016/0378-5122(95)00996-5.
3
The prevalence and severity of urinary incontinence in women.女性尿失禁的患病率及严重程度。
J Epidemiol Community Health. 1981 Mar;35(1):71-4. doi: 10.1136/jech.35.1.71.
4
Urinary incontinence and related urogenital symptoms in elderly women.老年女性的尿失禁及相关泌尿生殖系统症状
Acta Obstet Gynecol Scand Suppl. 1993;158:1-22. doi: 10.3109/00016349309156515.
5
Prevalence of urinary incontinence in middle-aged women.
Int J Gynaecol Obstet. 1988 Apr;26(2):255-9. doi: 10.1016/0020-7292(88)90270-6.
6
Risk factors for stress, urge or mixed urinary incontinence in Italy.意大利压力性、急迫性或混合性尿失禁的风险因素。
BJOG. 2003 Oct;110(10):927-33.
7
The urogenital system and the menopause.泌尿生殖系统与更年期。
Climacteric. 2015;18 Suppl 1:18-22. doi: 10.3109/13697137.2015.1078206.
8
The frequency of disorders of the lower urinary tract, urinary incontinence in particular, as evaluated by a questionnaire survey in a gynecological health control population.通过对妇科健康检查人群进行问卷调查评估下尿路疾病的发生率,尤其是尿失禁的发生率。
Acta Obstet Gynecol Scand. 1981;60(1):71-6. doi: 10.3109/00016348109154113.
9
Vaginal hormone therapy for urogenital and menopausal symptoms.用于治疗泌尿生殖系统症状和更年期症状的阴道激素疗法。
Semin Reprod Med. 2005 May;23(2):126-40. doi: 10.1055/s-2005-869480.
10
Hormone implants for urinary disorders in postmenopausal women.用于绝经后女性泌尿系统疾病的激素植入剂。
J Am Geriatr Soc. 1976 Aug;24(8):337-9. doi: 10.1111/j.1532-5415.1976.tb03308.x.

引用本文的文献

1
Demonstrating the principal mechanism of action of medical devices intended for vaginal use on reconstructed human vaginal epithelium: the case of two hyaluronic acid-containing devices.展示用于重建人类阴道上皮的阴道用医疗器械的主要作用机制:以两种含透明质酸的器械为例
Front Drug Saf Regul. 2024 Sep 17;4:1445519. doi: 10.3389/fdsfr.2024.1445519. eCollection 2024.
2
Efficacy of Non-Invasive Monopolar Radiofrequency for Treating Genitourinary Syndrome of Menopause: A Prospective Pilot Study.非侵入性单极射频治疗绝经后泌尿生殖综合征的疗效:一项前瞻性试点研究。
Clin Pract. 2025 Aug 20;15(8):155. doi: 10.3390/clinpract15080155.
3
Correlation between fall experience and life functions among community-dwelling older adults in Japan.
日本社区居住老年人跌倒经历与生活功能之间的相关性。
Dialogues Health. 2024 Nov 8;5:100198. doi: 10.1016/j.dialog.2024.100198. eCollection 2024 Dec.
4
A Novel Method for the Measurement of the Vaginal Wall Thickness by Transvaginal Ultrasound: A Study of Inter- and Intra-Observer Reliability.经阴道超声测量阴道壁厚度的新方法:一项观察者间和观察者内可靠性研究。
Medicina (Kaunas). 2024 Feb 22;60(3):370. doi: 10.3390/medicina60030370.
5
Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause.二极管阴道激光治疗绝经后泌尿生殖综合征的疗效
Bioengineering (Basel). 2023 Oct 2;10(10):1158. doi: 10.3390/bioengineering10101158.
6
Stigmatization as a Barrier to Urologic Care: A Review.污名化:泌尿外科护理的障碍——综述
Health Psychol Res. 2023 Sep 2;11:84273. doi: 10.52965/001c.84273. eCollection 2023.
7
Effects of Therapeutic Platelet-Rich Plasma on Overactive Bladder via Modulating Hyaluronan Synthesis in Ovariectomized Rat.富血小板血浆对去卵巢大鼠逼尿肌过度活动的治疗作用及其对透明质酸合成的调节作用。
Int J Mol Sci. 2023 May 4;24(9):8242. doi: 10.3390/ijms24098242.
8
Low-Intensity Extracorporeal Shock Wave Therapy Promotes Bladder Regeneration and Improves Overactive Bladder Induced by Ovarian Hormone Deficiency from Rat Animal Model to Human Clinical Trial.低强度体外冲击波疗法促进膀胱再生,并改善卵巢激素缺乏所致的膀胱过度活动症:从大鼠动物模型到人体临床试验。
Int J Mol Sci. 2021 Aug 27;22(17):9296. doi: 10.3390/ijms22179296.
9
An Open, Uncontrolled Pilot Study on 12-Week Use of VagiVital for Treatment of Vulvovaginal Atrophy in Breast Cancer Patients Undergoing Adjuvant Aromatase-Inhibitor Therapy.一项关于VagiVital用于接受辅助芳香化酶抑制剂治疗的乳腺癌患者外阴阴道萎缩治疗12周的开放性、非对照性试点研究。
Med Devices (Auckl). 2021 Jun 25;14:193-200. doi: 10.2147/MDER.S303234. eCollection 2021.
10
Bladder Hyperactivity Induced by Oxidative Stress and Bladder Ischemia: A Review of Treatment Strategies with Antioxidants.氧化应激和膀胱缺血引起的膀胱过度活动症:抗氧化剂治疗策略的综述。
Int J Mol Sci. 2021 Jun 2;22(11):6014. doi: 10.3390/ijms22116014.